Wednesday, January 25, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

Novel Genomic Technology Development

by Global Biodefense Staff
October 27, 2015
NIAID Priority Pathogen Countermeasures

The National Human Genome Research Institute (NHGRI) is seeking grant applications from academia and industry in order to catalyze next-generation advances in genomics through technology development.

The goal is to provide a mechanism for support of very novel and high impact work from across this gamut of genomics technology development, support technologies that will have a major impact in the next five to seven years.

Technology advances, particularly new sequencing systems, have enabled many research projects that are producing stunning insights into biology and disease.  Extending beyond sequence per se, assays have been developed to determine nucleotide modifications, chromatin state, nuclear organization, and dynamics of those features.

Nevertheless, the cost to assay completely important features of genomes of individual cells or people remains high and the assays are complex, and we remain far from achieving the low costs and high quality needed to use comprehensive genomic information in many research applications or in individual health care.

Any proposed technology development work should allow comprehensive genomic analysis of features not assayable today, or an increase of at least an order of magnitude improvement in an existing technology in terms of data quality, throughput, efficiency or comprehensiveness.

Examples of possible research topics are:

  • DNA, RNA, epigenome, transcriptome, chromatin, etc. from the same sample
  • High throughput genome modifications (e.g., by recombination and transient assays using reporter or in situ assays), for replacement, activation and inhibition, with genomic readout
  • Cost-effective scaling genomic assays
  • In situ methods (tissue context) for DNA, epigenome, other functional assays, and RNA analyses
  • Measuring proximal transcription dynamics, and transcriptome dynamics over time

Further details are available in the collection of solicitations related to the Genomic Technology development effort:

  • PAR-16-014 R01 Research Project Grant
  • PAR-16-015 R21 Exploratory/Developmental Grant
  • PAR-16-016 R43/R44 Small Business Research Grant
  • PAR-16-017 R44 Small Business Research Grant, Direct to Phase II

These funding opportunities explicitly exclude the development of technologies for DNA sequencing and for direct RNA sequencing; those projects should respond to parallel solicitations RFA-HG-15-031, RFA-HG-15-032, and RFA-HG-15-033.

Tags: Request for Proposals

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
The device appears smaller than a playing card, transparent, with visible channels branching off.
Medical Countermeasures

How Organ-on-a-chip Models Could Grease the Drug Development Pipeline

January 10, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC